- Home
- GYRE vs PFC Comparison
GYRE vs PFC Comparison
Compare GYRE & PFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GYRE
- PFC
- Stock Information
- Founded
- GYRE 2002
- PFC 1920
- Country
- GYRE United States
- PFC United States
- Employees
- GYRE N/A
- PFC N/A
- Industry
- GYRE Biotechnology: Pharmaceutical Preparations
- PFC Major Banks
- Sector
- GYRE Health Care
- PFC Finance
- Exchange
- GYRE Nasdaq
- PFC Nasdaq
- Market Cap
- GYRE 1.1B
- PFC 898.9M
- IPO Year
- GYRE N/A
- PFC N/A
- Fundamental
- Price
- GYRE $12.02
- PFC $27.62
- Analyst Decision
- GYRE
- PFC Hold
- Analyst Count
- GYRE 0
- PFC 4
- Target Price
- GYRE N/A
- PFC $22.50
- AVG Volume (30 Days)
- GYRE 91.0K
- PFC 211.8K
- Earning Date
- GYRE 03-25-2025
- PFC 01-21-2025
- Dividend Yield
- GYRE N/A
- PFC 4.45%
- EPS Growth
- GYRE N/A
- PFC N/A
- EPS
- GYRE N/A
- PFC 1.98
- Revenue
- GYRE $105,033,000.00
- PFC $249,701,000.00
- Revenue This Year
- GYRE $25.32
- PFC N/A
- Revenue Next Year
- GYRE $12.95
- PFC $7.69
- P/E Ratio
- GYRE N/A
- PFC $14.07
- Revenue Growth
- GYRE N/A
- PFC N/A
- 52 Week Low
- GYRE $8.26
- PFC $18.63
- 52 Week High
- GYRE $26.37
- PFC $29.63
- Technical
- Relative Strength Index (RSI)
- GYRE 54.44
- PFC 56.53
- Support Level
- GYRE $11.18
- PFC $25.11
- Resistance Level
- GYRE $11.85
- PFC $28.46
- Average True Range (ATR)
- GYRE 0.52
- PFC 0.86
- MACD
- GYRE 0.14
- PFC 0.29
- Stochastic Oscillator
- GYRE 83.91
- PFC 70.79
About GYRE Gyre Therapeutics Inc.
Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States. In the United States, Hydronidone is currently being evaluated for the treatment of liver fibrosis across a broad spectrum of chronic liver diseases under an active Investigational New Drug (IND) application. Gyre is also advancing a diverse pipeline in China through a controlling interest in the Beijing Continent, including pirfenidone, F573, F528, and F230.
About PFC Premier Financial Corp.
Premier Financial Corp is a financial holding company that operates as a community banking and financial services corporation. It offers a broad range of financial services through its subsidiaries including checking accounts, savings accounts, certificates of deposit, real estate mortgage loans, commercial loans, consumer loans, home equity loans, and trust and wealth management services.